Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the injectable drugs.
Drawing on cutting-edge technology and interdisciplinary expertise, researchers are launching Menopause Health Engineering, a new initiative to uncover how menopause shapes health and disease.
Teams of health care providers called Accountable Care Organizations participating in the Medicare Shared Savings Program have saved Medicare between $4.1 billion and $8.1 billion from 2012–2019, according to a new study from Weill Cornell Medicine investigators.
A new innovation from Cornell researchers lowers the energy use needed to power artificial intelligence – a step toward shrinking the carbon footprints of data centers and AI infrastructure.
The MyCoast New York app has already provided forecasters and emergency managers with a new understanding of flooding around the state, as sea levels rise and storms intensify.
The modification commonly found on messenger RNAs plays a surprisingly large role in how cells respond to stress, according to a study led by Weill Cornell Medicine investigators.
New Cornell research reveals that social media users with disabilities prefer more personalized content moderation powered by AI systems that not only hide harmful content but also summarize or categorize it by the specific type of hate expressed.
With the start of a new semester comes a fresh opportunity to engage with AAP colleagues and guests, explore concepts on campus and in the field, and find inspiration in the work and ideas on display at every turn.